You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國同輻(01763.HK)2021年淨利3.36億元 同比增長57.2%
格隆匯 03-30 21:06

格隆匯3月30日丨中國同輻(01763.HK)公吿,2021年,持續加大市場開拓力度,經濟效益實現較快增長,全年實現收益人民幣51.44億元,同比增長20.3%;歸屬於公司權益股東淨利潤人民幣3.36億元,同比增長57.2%。每股盈利1.05人民幣元。

截至2021年12月31日止年度,公司經營五個業務分部,包括藥品、放射源產品、輻照、獨立醫學檢驗實驗室服務及其他業務,以及放射治療設備及相關服務。報吿期內,集團藥品實現營業收入人民幣37.5億元,同比增長26.0%。

報吿期內,集團旗下各醫學檢驗中心堅持在抗擊新冠疫情的前線,積極開展新型冠狀病毒核酸檢測相關工作。在北京、成都、武漢、合肥相繼開設了核酸檢測採樣點,面向個人提供核酸採樣服務,並提供上門採樣的服務。還承接了冬奧會部份人員核酸檢測的工作等。除核酸項目,在血液檢測項目上也加大推廣力度,積極開拓體檢市場,與多家體檢中心簽訂合作協議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account